Erste Group Bank Issues Positive Forecast for ISRG Earnings

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Stock analysts at Erste Group Bank lifted their FY2027 earnings per share (EPS) estimates for shares of Intuitive Surgical in a research report issued to clients and investors on Thursday, October 8th. Erste Group Bank analyst H. Engel now expects that the medical equipment provider will post earnings of $10.09 per share for the year, up from their previous forecast of $10.06. The consensus estimate for Intuitive Surgical’s current full-year earnings is $8.87 per share.

A number of other research firms also recently weighed in on ISRG. Mizuho set a $500.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. TD Cowen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, July 28th. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Royal Bank Of Canada dropped their price objective on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a report on Monday, July 13th. Finally, BTIG Research cut their target price on Intuitive Surgical from $469.00 to $454.00 and set a “buy” rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $501.98.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $427.64 on Tuesday. Intuitive Surgical has a 1 year low of $328.57 and a 1 year high of $603.88. The firm has a 50 day moving average price of $387.41 and a 200 day moving average price of $410.47. The company has a market cap of $151.08 billion, a price-to-earnings ratio of 48.99, a PEG ratio of 3.20 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.81 EPS.

Insider Buying and Selling

In other news, VP Fredrik Widman sold 1,089 shares of the firm’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total value of $407,765.16. Following the transaction, the vice president owned 1,026 shares of the company’s stock, valued at approximately $384,175.44. This trade represents a 51.49% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 10,000 shares of Intuitive Surgical stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the transaction, the director owned 1,245,679 shares in the company, valued at $498,271,600. The trade was a 0.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of ISRG. 3Chopt Investment Partners LLC boosted its holdings in Intuitive Surgical by 5.2% in the 1st quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider’s stock worth $213,000 after acquiring an additional 23 shares during the period. Vermillion Wealth Management Inc. raised its stake in shares of Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares during the period. W.G. Shaheen & Associates DBA Whitney & Co raised its stake in shares of Intuitive Surgical by 1.0% during the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock valued at $1,172,000 after purchasing an additional 25 shares during the period. Blue Fin Capital Inc. lifted its position in shares of Intuitive Surgical by 0.5% during the first quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock worth $2,210,000 after purchasing an additional 25 shares in the last quarter. Finally, Red Spruce Capital LLC lifted its position in shares of Intuitive Surgical by 4.1% during the second quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider’s stock worth $255,000 after purchasing an additional 25 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: UBS reiterated a Buy rating and maintained its $500 price target, citing Intuitive Surgical’s long-term robotic surgery growth runway. The target implies meaningful upside from recent trading levels. Intuitive Surgical Buy Rating Reiterated on Long-Term Robotic Growth Runway
• Positive Sentiment: Erste Group Bank raised its FY2027 EPS forecast to $10.09 from $10.06. Although the increase was modest, the estimate remains well above the current-year consensus of $8.87, reinforcing expectations for continued earnings growth.
• Positive Sentiment: A recent comparison with Abbott Laboratories highlighted Intuitive Surgical’s stronger growth profile, including approximately 20% revenue growth, zero debt and significant long-term expansion potential. Those strengths support the premium valuation investors assign to ISRG, though the stock trades at a much higher multiple.
• Neutral Sentiment: Intuitive Surgical is expected to report quarterly earnings on Tuesday. The results and management’s outlook could drive the next significant move, particularly given the stock’s elevated valuation and high investor expectations. Intuitive Surgical Expected to Post Quarterly Earnings
• Negative Sentiment: BTIG lowered its price target to $454 from $469, while retaining a Buy rating. The reduction suggests more limited near-term upside than previously expected and offsets some of the optimism from UBS. Intuitive Surgical Stock Price Target Lowered at BTIG Research

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.